Oxidized phospholipids, Lp(a) and coronary heart disease risk

Oxidized phospholipids, Lp(a) and coronary heart disease risk

Bibliographic Details
Main Authors:	Clarke, R, Hopewell, J, Tsimikas, S, Watkins, H, Farrall, M, Consortium, PROCARDIS
Format:	Conference item
Published:	2012

Similar Items

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
by: Hopewell, J, et al.
Published: (2010)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
by: Farrall, M, et al.
Published: (2010)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
by: Clarke, R, et al.
Published: (2012)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
by: Seedorf, U, et al.
Published: (2010)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
by: Clarke, R, et al.
Published: (2009)

Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formation
by: Sundeep Ruder, et al.
Published: (2022-11-01)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
by: Clarke, R, et al.
Published: (2018)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
by: Clarke, R, et al.
Published: (2009)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
by: Hopewell, J, et al.
Published: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
by: Hopewell, J, et al.
Published: (2014)

Evidence from a family based study of gene association of lymphotoxin alpha with coronary artery disease (CAD)
by: Green, F, et al.
Published: (2004)

Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
by: Corey A. Scipione, et al.
Published: (2015-12-01)

The role of oxidized phospholipids in atherosclerosis
by: Judith A. Berliner, et al.
Published: (2009-01-01)

Multiple QTL influence the serum Lp(a) concentration: A genome-wide linkage screen in the PROCARDIS study
by: Barlera, et al.
Published: (2007)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
by: Kyriakou, T, et al.
Published: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
by: Kyriakou, T, et al.
Published: (2014)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
by: Hopewell, J, et al.
Published: (2012)

Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer’s disease
by: Grace, PC, et al.
Published: (2018)

Independent relevance of renal function for coronary artery disease
by: Hopewell, J, et al.
Published: (2010)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
by: Clarke, R, et al.
Published: (2023)

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP
by: Goel, A, et al.
Published: (2009)

A Genome-Wide Association Study of Risk of Coronary Artery Disease in European and South Asian Populations
by: Hopewell, J, et al.
Published: (2010)

USE OF ENCODE DATA TO IDENTIFY PUTATIVE FUNCTIONAL VARIANTS IN CORONARY ARTERY DISEASE GWAS
by: Goel, A, et al.
Published: (2014)

Genetic susceptibility to coronary artery disease: from promise to progress.
by: Watkins, H, et al.
Published: (2006)

LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
by: Kyriakou, T, et al.
Published: (2014)

Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
by: Mika Hilvo, et al.
Published: (2020-05-01)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
by: Hopewell, J, et al.
Published: (2011)

Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17
by: Farrall, M, et al.
Published: (2006)

Is LP(a), as Predictor of Severity of Coronary Artery Disease?
by: Hassan Shemirani, et al.
Published: (2009-07-01)

In search of a physiological function of lipoprotein(a): causality of elevated Lp(a) levels and reduced incidence of type 2 diabetes1
by: Sotirios Tsimikas
Published: (2018-01-01)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
by: Farrer, M, et al.
Published: (1993)

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.
by: Elliott, P, et al.
Published: (2009)

Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet
by: Nastaran Faghihnia, et al.
Published: (2010-11-01)

Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus
by: Karam M. Kostner, et al.
Published: (2022-03-01)

Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia1
by: Kiyohito Arai, et al.
Published: (2012-08-01)

Homocysteine and coronary heart disease.
by: Clarke, R, et al.
Published: (2002)

Paraoxonase polymorphisms and coronary heart disease - Reply
by: Wheeler, J, et al.
Published: (2004)

Changes and significance of serum monocyte chemoattractant protein-1 and Lp-PLA2 in patients with hypertension and coronary heart disease
by: Yongbo Tian, et al.
Published: (2022-02-01)

GENETIC LOCI INFLUENCING C-REACTIVE PROTEIN LEVELS AND CORONARY HEART DISEASE RISK: RESULTS OF GENETIC ASSOCIATION AND MENDELIAN RANDOMISATION STUDY WITH META-ANALYSIS IN 80 614 PEOPLE
by: Elliott, P, et al.
Published: (2009)

CHANGES RANGE OF FATTY ACID PLATELETS PHOSPHOLIPID MEMBRANES IN CORONARY HEART DISEASE COMBINED WITH PAROXYSMALATRIAL FIBRILLATION PATIENTS
by: /. Merkulova, et al.
Published: (2015-09-01)